Clinical Trial

A Study to Evaluate the Impact of Pre-procedural Intracoronary Nicorandil Injection to PREVENT ReductioN of DecREased TIMI FLOW in Patients Who Undergoing Percutaneous Coronary Intervention for the Coronary Artery Disease

Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated October 10, 2024 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
The aim of this study was to determine the effect of intra-coronary administration of nicorandil on the prevention of lowering of coronary blood flow for high-risk plaque lesions defined as the high value of lipid core burden index in patients with coronary artery disease who require stent treatment.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2022-06-16; most recent amendment 2024-10-08.
Status change: Not Yet Recruiting → Recruiting 2022-12-16
Trial Details
NCT Number NCT05427786
Lead Sponsor Korea University Anam Hospital
Conditions No-Reflow Phenomenon, Coronary Artery Disease, Percutaneous Coronary Intervention
Enrollment 460 participants
Start Date 2022-12-14
Primary Completion 2026-07 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2024-10-10